TPF+CCRT

DRUG3 trials

Sponsors

Sun Yat-sen University, Guiyang Medical University

Conditions

Locally Advanced Nasopharyngeal CarcinomaNasopharyngeal Carcinoma

Phase 3

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Active, not recruitingNCT03306121

Sun Yat-sen UniversityNasopharyngeal Carcinoma

Start: 2017-11-13End: 2026-12-31Target: 322Updated: 2023-05-22

TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

Guiyang Medical UniversityLocally Advanced Nasopharyngeal Carcinoma

Start: 2018-05-24End: 2023-05-24Target: 266Updated: 2018-07-02

GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

Guiyang Medical UniversityLocally Advanced Nasopharyngeal Carcinoma

Start: 2018-07-21End: 2020-07-21Target: 204Updated: 2018-07-30

Related Papers

Induction TPF versus adjuvant PF after CCRT in locally advanced nasopharyngeal carcinoma: A multicenter, randomized controlled phase III clinical trial.

2026-08-16

A multicenter, randomized controlled phase III trial of TPF induction chemotherapy versus PF adjuvant chemotherapy combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: Long-term follow-up analysis.

Journal of Clinical Oncology2026-05-27

Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma

JAMA Oncology2025-06-184 citations

[Special entities of the head and neck region: cancers of the nasopharynx, (para)nasal cavities, salivary glands, and the thyroid gland : Post ASCO 2024].

2024-11-08

Induction-concurrent versus concurrent-adjuvant chemoradiotherapy in patients with high-risk N2–3 nasopharyngeal carcinoma: An open-label, randomised, controlled, phase 3 trial.

Journal of Clinical Oncology2024-06-013 citations